1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2) Peptid
AGPAT2
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle AGPAT2 Produkte
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- LEAIPTSGLT AADVPALVDT CHRAMRTTFL HISKTPQENG ATAGSGVQPA
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of AGPAT2 antibody,
Alternative Names: AGPAT2 control peptide, AGPAT2 antibody Blocking Peptide, Anti-AGPAT2 Blocking Peptide, 1-Acylglycerol-3-Phosphate O-Acyltransferase 2 Blocking Peptide, ,1-AGPAT2 Blocking Peptide, BSCL Blocking Peptide, BSCL1 Blocking Peptide, LPAAB Blocking Peptide, LPAAT-beta Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
- Hintergrund
- AGPAT2 is a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in its gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance.
- Molekulargewicht
- 27 kDa
-
Sie sind hier:
